Summary
This 8-K filing from Edwards Lifesciences Corp (EW) on July 28, 2015, primarily serves to furnish their press release detailing the company's second-quarter 2015 financial results. Investors should note that while this filing incorporates the press release by reference, the information is furnished, not officially 'filed' under the Securities Exchange Act of 1934. Therefore, the focus for detailed analysis should be on the content of the provided press release (Exhibit 99.1), which contains the specific financial performance data for the quarter.
Key Highlights
- 1Edwards Lifesciences released its financial results for the second quarter of 2015 on July 28, 2015.
- 2The 8-K filing includes a press release (Exhibit 99.1) containing the Q2 2015 financial results.
- 3The information furnished under Item 2.02 is not considered 'filed' for the purposes of the Securities Exchange Act.
- 4This filing acts as a mechanism to provide the market with timely financial performance updates.
- 5Investors should refer to Exhibit 99.1 for the detailed financial performance of Edwards Lifesciences in Q2 2015.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally furnish Edwards Lifesciences' press release containing their financial results for the second quarter of 2015, which was issued on July 28, 2015.
The detailed financial results for the second quarter of 2015 are found in the press release, which is included as Exhibit 99.1 to this 8-K filing.
No, the information furnished under Item 2.02 of this filing, including the press release, is furnished and not deemed 'filed' for the purposes of the Securities Exchange Act of 1934. This means it does not carry the same legal implications as a formally filed document.
This 8-K filing itself does not contain the specific financial metrics. For detailed information on revenue, earnings, and other financial performance indicators for the second quarter of 2015, investors must refer to the furnished press release (Exhibit 99.1).